《全日總結》恆指升34點 藥明生物彈近8% 商湯挫逾7%
港股今日先跌後升。恆指低開331點,初段曾跌424點一度見19,885點,其後跌幅收窄,並以全日高位20,344點收市,倒升34點或0.17%。國指升8點或0.1%,收6,875點;恆生科技指數跌6點或0.2%,收4,159點。大市全日成交總額1,099.95億元,滬、深港通南下交易淨流入17.88億及16.99億元人民幣。
醫藥股上升,藥明生物(02269.HK)升7.8%,為升幅最大藍籌。中生製藥(01177.HK)、翰森(03692.HK)及信達生物(01801.HK)升逾3%,白雲山(00874.HK)、藥明康德(02359.HK)、康龍化成(03759.HK)及百濟神州(06160.HK)升4.4%至6%、金斯瑞(01548.HK)升7.9%。
日本軟銀據報透過遠期合約大幅減持阿里巴巴(09988.HK),阿里巴巴跌2%報94.15元。京東(09618.HK)遭多間券商下調目標價及收入預測,股價跌2%。其他科技股方面,騰訊(00700.HK)升1.7%報363.2元,快手(01024.HK)及微博(09698.HK)升1.2%及跌1.3%。萬國數據(09698.HK)及金山雲(03896.HK)各跌3.1%及2.6%。商湯(00020.HK)股價跌7.6%。
市場關注汽車減價戰蔓延至新能源車,蔚來(09866.HK)及小鵬(09868.HK)各跌2.3%及1.5%,理想(02015.HK)升3.2%。華晨(01114.HK)遭花旗下調投資評級,股價跌4.1%。體育用品股安踏(02020.HK)股價跌1.2%。李寧(02331.HK)倒升2.4%。此外,維達(03331.HK升2.9%,康師傅(00322.HK)及維他奶(00345.HK)各升3%及4%。
內房股融創中國(01918.HK)復牌,全日股價跌55.5%報2.04元,成交逾16.3億元。其餘內房股普遍下跌,碧桂園(02007.HK)、富力(02777.HK)及遠洋(03377.HK)跌逾2%。龍湖(00960.HK)升2.5%。地產軟件股明源雲(00909.HK)續跌4.2%。
金融股方面,匯控(00005.HK)升0.9%報55.25元,港交所(00388.HK)升0.3%,友邦(01299.HK)跌1.1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.